Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-08
2009-06-09
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S264110, C514S252160, C544S117000, C544S230000, C544S279000, C544S377000, C546S019000, C546S220000, C549S439000, C549S447000
Reexamination Certificate
active
07544682
ABSTRACT:
The disclosure concerns pyrido[2,3-d]pyrimidine derivatives, their preparation and their therapeutic application, of general formula (I)and acid addition salts, hydrates and solvates thereof, as well as in the form of enantiomers, diastereoisomers and mixtures thereof. The disclosure also concerns methods for preparing said derivatives, pharmaceutical compositions containing a compound of general formula (I), and their therapeutic use.
REFERENCES:
patent: 5620981 (1997-04-01), Blankley et al.
patent: 5733913 (1998-03-01), Blankley et al.
patent: 5733914 (1998-03-01), Blankley et al.
patent: 5952342 (1999-09-01), Blankley et al.
patent: WO 96/15128 (1996-05-01), None
patent: WO 01/55147 (2001-08-01), None
patent: WO 01/70741 (2001-09-01), None
patent: WO 03/000011 (2003-01-01), None
patent: WO 2004/085436 (2004-10-01), None
Sicinski, BBC News/Health, Killer Breast Cancer Therapy Hope, Jan. 21, 2006.
Walsh, BBC News, International Version, Medical Notes, Feb. 1, 2007.
PharmaLicensing (Mar. 2005).
Schroeder et al, Soluble 2-Substituted Aminopyrido[2,3-d]primidin-7-yl Ureas. Structure—Activity Relationships against Selected Tyrosine Kinases and Exploration of in Vitro and in Vivo Anticancer Activity, J. Med. Chem., 2001, 44, 1915-1926.
Thompson et al, Synthesis and Structure—Activity Relationships of Soluble 7-Substituted 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridin-2-amines and Related Ureas as Dual Inhibitors of the Fibroblast Growth Factor Receiptor-1 and Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinases, J. Med. Chem., 2005, 48, 4628-4653.
U.S. Appl. No. 11/955,583, filed Dec. 13, 2007, Bourrie.
Bourrie Bernard
Casellas Pierre
Jegham Samir
Perreaut Pierre
Bender Kelly L.
Berch Mark L
Jaisle Cecilia M
Sanofi-Aventis
LandOfFree
Pyrido-pyrimidine derivatives, preparation thereof, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrido-pyrimidine derivatives, preparation thereof, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrido-pyrimidine derivatives, preparation thereof, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063271